Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
Clinical trial NCT03991143 · COMPLETED
Trial details
- NCT number
- NCT03991143
- Sponsor
- Athera Biotechnologies AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2020-07-06
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.